Literature DB >> 26040552

Obesity: Lifestyle management, bariatric surgery, drugs, and the therapeutic exploitation of gut hormones.

Preeshila Behary1, Jaimini Cegla, Tricia M Tan, Stephen R Bloom.   

Abstract

Obesity is on the rise and the pursuit of efficient and safe treatment is ongoing. Available anti-obesity medical therapies have so far proved to be disappointing, whereas bariatric surgery is leading the way and offers long-term health benefits. Part of the success of bariatric surgery is thought to be mediated by gut hormones. A better understanding of the role of gut hormones within the gut-brain signaling pathway in the control of hunger, satiety, and energy homeostasis, has led to their therapeutic exploitation as possible anti-obesity drugs. In this review, we provide a summary of currently available treatment options for obesity from simple lifestyle modifications and bariatric surgery to traditional and novel medical therapies.

Entities:  

Keywords:  Obesity; bariatric surgery; drugs; gut hormones; lifestyle management

Mesh:

Substances:

Year:  2015        PMID: 26040552     DOI: 10.1080/00325481.2015.1048181

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  5 in total

1.  Post-prandial anorexigenic gut peptide, appetite and glucometabolic responses at different eating rates in obese patients undergoing laparoscopic sleeve gastrectomy.

Authors:  Antonello Emilio Rigamonti; Silvia Bini; Maria Cristina Rocco; Vittorio Giardini; Diego Massimini; Maria Grazia Crippa; Antonella Saluzzi; Marco Casati; Nicoletta Marazzi; Mario Perotti; Vincenzo Cimino; Guido Grassi; Alessandro Sartorio; Angela Ida Pincelli
Journal:  Endocrine       Date:  2016-03-29       Impact factor: 3.633

2.  Canola oil rich in oleic acid improves diastolic heart function in diet-induced obese rats.

Authors:  Sijo Joseph Thandapilly; Pema Raj; Xavier Lieben Louis; Danielle Perera; Prasanga Yamanagedara; Peter Zahradka; Carla G Taylor; Thomas Netticadan
Journal:  J Physiol Sci       Date:  2016-12-01       Impact factor: 2.781

3.  Unmet Needs in the Treatment of Gastroesophageal Reflux Disease.

Authors:  Ram Dickman; Carla Maradey-Romero; Rachel Gingold-Belfer; Ronnie Fass
Journal:  J Neurogastroenterol Motil       Date:  2015-07-30       Impact factor: 4.924

Review 4.  Naltrexone HCI/bupropion HCI for chronic weight management in obese adults: patient selection and perspectives.

Authors:  Cenk Tek
Journal:  Patient Prefer Adherence       Date:  2016-05-04       Impact factor: 2.711

Review 5.  How do patients' clinical phenotype and the physiological mechanisms of the operations impact the choice of bariatric procedure?

Authors:  Thomas Bächler; Carel W le Roux; Marco Bueter
Journal:  Clin Exp Gastroenterol       Date:  2016-07-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.